VBIV - VBI VACCINES INC.

0.0653
0   0%

Share volume: 294,352
Last Updated: 08-07-2024

PREVIOUS CLOSE
CHG
CHG%
$0.07
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.07
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
-$4.29
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
28.682 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Jeffrey R. Baxter
Region: US
Website: www.vbivaccines.com
Employees: 22
IPO year: 1995
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

VBI Vaccines Inc. develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for chronic HBV infection.

Recent news